Featured Articles

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By August 17, 2020August 19th, 2024No Comments

Featured Article

Featured Article

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Read more

This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Adele Shenoy BA, Raman Madan MD

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis, as well as external factors such as burns and radiation therapy. An understanding of treatment strategies for PIH is essential, as it has a large impact on the quality of life.

Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies specifically address PIH. Thus, we conducted a literature review on PubMed using key words “post-inflammatory hyperpigmentation” OR “postinflammatory hyperpigmentation.”

Studies that did not specifically address PIH and articles that were not published in English were excluded. Additional studies were obtained by scanning references. This review adds to the current literature by discussing the evidence for topical therapies, chemical peels, and laser therapy used specifically for hyperpigmentation from PIH.

Read Full Article Now
Article Cited in this Post

Inclusive Derm Atlas PIH Images

You May Also Like

Journal of Drugs in Dermatology JDD Article about Critical Insights on Preparation of Platelet-Rich Plasma in Tubes With a Thixotropic Gel Separator

From the Vault: Critical Insights on Preparation of Platelet-Rich Plasma in Tubes With a Thixotropic Gel Separator

| Featured Articles, Latest News, Medical Derm | No Comments
Don’t lose platelets to the gel: simple tweaks boost PRP yield from thixotropic systems We are pulling out this must-read article from the vault. This brief report from the November…
Journal of Drugs in Dermatology JDD Article about The Current Landscape of Treatment of Warts

The Current Landscape of Treatment of Warts

| Featured Articles, Latest News, Medical Derm | No Comments
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability Warts are caused by non‑enveloped double‑stranded DNA human papillomaviruses and, while two‑thirds…
Journal of Drugs in Dermatology JDD Article about Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

| Featured Articles, Hidradenitis Suppurativa, Latest News, Skin of Color | No Comments
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…

Leave a Reply